Seraxis: Funding, Investors & Team (Sep 2026)
Seraxis, a private biotechnology company established in March 2013, is based in Singapore and the United States with its GMP laboratory situated in Germantown, Maryland. The company's team of researchers has created innovative cell and encapsulation technologies with the aim of developing a viable cell therapy for insulin-dependent diabetes that offers a long-term solution without the need for immuno-suppression. Their corporate setup and approach are specifically tailored to expedite progress towards this objective, all while delivering significant value to their stakeholders.
Seraxis has raised $40.4M across 3 funding rounds on record, the most recent an undisclosed round announced in May 2025.
Seraxis Company Profile and Key Stats
Latest funding round on record: May 2025.
Seraxis Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Seraxis raised $40.0M in a Series C announced in Feb 2021.
3.3 years later, an undisclosed round of $400k was announced in Jun 2024.
11 months later, an undisclosed round was announced in May 2025 with no disclosed amount.
Seraxis Founders and Leadership Team
Contact details for the Seraxis team: 2 of 2 have an email address on file.
Start 14-day free trial →Seraxis Funding Compared to Other Biotechnology Startups
Funded Startups Like Seraxis in Biotechnology and Germantown
Companies Similar to Seraxis
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Seraxis Funding FAQs
What does Seraxis do?
Seraxis, a private biotechnology company established in March 2013, is based in Singapore and the United States with its GMP laboratory situated in Germantown, Maryland. The company's team of researchers has created innovative cell and encapsulation technologies with the aim of developing a viable cell therapy for insulin-dependent diabetes that offers a long-term solution without the need for immuno-suppression. Their corporate setup and approach are specifically tailored to expedite progress towards this objective, all while delivering significant value to their stakeholders.
How much funding has Seraxis raised?
Seraxis has raised $40.4M across 3 rounds on record.
When did Seraxis last raise funding?
Seraxis' most recent funding round on record was announced in May 2025. The amount was not disclosed.
Who founded Seraxis?
FundedIQ lists Carole Welsch (Founder) at Seraxis.
Who is the CEO of Seraxis?
William Rust is listed as CEO at Seraxis.
Where is Seraxis headquartered?
Seraxis is based in Germantown, Maryland, United States.
How many employees does Seraxis have?
Seraxis is in the 11-50 employee band.
About FundedIQ's Seraxis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seraxis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.